Today is #WorldPPDay. Do you know what Periodic Paralysis (PP) is? PP is characterized by repeated episodes of extreme muscle weakness and temporary paralysis. Without a known family history of PP, it takes patients 26 years to receive a diagnosis. worldperiodicparalysisday.com

We are pleased to announce that Cycle Vita™ is now available with BAFIERTAM® (monomethyl fumarate) delayed-release capsules. Read more here: cyclepharma.com/news/bafiertam…

It is an honour to be chosen for the Leadership Team Award at the #SundayTimes100 Tech & be listed alongside inspirational British companies. Thank you Richard Tyler, Hannah Prevett, Ying van de Walle at Times Business, and Ian McBane at BDO UK.

Come and speak to our Nephrology Team at @NFK_NephPros' Spring Clinical Meetings 2025, to learn about Cycle Pharma's new Cystinuria product.

Cycle Vita PKU™ #applaunch for on-the-go management of #Phenylketonuria (PKU). This #AIpowered app is designed to offer flexible and timely support for patients with PKU, who require lifelong adherence to a strict diet, medication and formula. Learn more: cyclepharma.com/news/cycle-vit…

Come and meet our Nephrology Team at the Amer. Urol. Assn.'s Annual Meeting in Las Vegas, to learn about how Cycle Vita™ can support your patients with Cystinuria. #AUA #Urology

🤝 We thank Cycle Pharmaceuticals for supporting flok Family Camps and joining our upcoming community fairs! 🎪 Join us at Family Camp to chat with Cycle in person. 👉 Register & learn more at flok.org/camp #CyclePharma #flokFamilyCamp #IMD #TYR #PKU

Every 5 minutes, there is a new MS diagnosis in the world. For #WorldMSDay this year, patients are sharing their stories with #MyMSDiagnosis. World MS Day Throughout May, our team has been actively supporting MS Walks. Come and say hi if you see us at an event.

We are excited to announce that we have been ranked 50th in @FEBE Growth 100, listing Britain's fastest-growing companies! See the list here: febe.com #CyclePharma #FEBE #PatientFirst #RareDisease

Cycle Pharmaceuticals receives FDA approval for the first and only treatment in the U.S. for patients with Alkaptonuria (AKU) Learn more: cyclepharma.com/news/first-fda…

Cycle Pharmaceuticals’ HARLIKU™ (nitisinone) Tablets Receive First FDA-Approval as Treatment for Alkaptonuria (AKU) - For More Information Visit shorturl.at/DuhIg Cycle Pharmaceuticals #Alkaptonuria #FDA #AKU

June 28th is #InternationalPKUDay! A day to spotlight PKU, a rare disorder affecting protein metabolism. Check out our free Cycle Vita PKU app and our new series on Facebook for a weekly low-protein recipe! facebook.com/CycleVitaUSA #PKU #RareDisease #CycleVita

A huge thank you to all of our Bronze Sponsors for supporting the 2025 NPKUA Regional Community Conference this September in San Diego! Your partnership helps make this meaningful day possible for the PKU community. Secure your conference spot today! bit.ly/4jH7OCt

We are thrilled to be a finalist at the BDO UK #PrivateBusinessAwards! Proud to be recognized for our mission of advancing patient care through innovation. Find out more here👉privatebusinessawards.co.uk #CyclePharma #celebratePBA #PatientFirst

🍎🖍️Calling all kindergarten parents! We are excited to announce the launch of our new Kindergarten Kits, free for individuals with PKU. Starting school is a big step, and this kit is designed to support this new transition. Visit bit.ly/3IgRY4M to request your kit!

We had a great time at Camp PHEver last week! This event gives children and teens with PKU a place to come together and enjoy a classic camp experience while staying on track with necessary diet restrictions. Check out the campers' great work at our bracelet-making station!

Cycle Pharmaceuticals announced the launch of HARLIKU™ (nitisinone) Tablets, the first and only FDA-approved treatment for reducing urinary homogentisic acid (HGA) in adult patients with #alkaptonuria (AKU). Learn more: cyclepharma.com/news/harliku-n…

We are thrilled to announce an exciting new partnership with Handa Therapeutics, LLC. This collaboration extends our expertise in caring for patients living with chronic conditions into oncology. Read about the full announcement details here: cyclepharma.com/news/exclusive…